Sunesis Pharmaceuticals to Present at Pacific Growth Equities 2006 Life Sciences Growth Conference
June 08 2006 - 8:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., June 8 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Jim Young, Executive Chairman, will present a company update at the
Pacific Growth Equities 2006 Life Sciences Growth Conference. The
presentation will take place on Monday, June 12, 2006 at 1:30 p.m.
at The InterContinental Mark Hopkins Hotel, San Francisco, CA.
Interested parties may access a webcast of the presentation by
visiting the Sunesis website at http://ir.sunesis.com/. A replay of
the webcast will be archived on the "Calendar of Events" page in
the Investors and Media section of the Sunesis website for two
weeks until June 26, 2006. About Sunesis Pharmaceuticals Sunesis is
a clinical-stage biopharmaceutical company focused on the
discovery, development and commercialization of novel small
molecule therapeutics for oncology and other serious diseases.
Sunesis has built a broad product candidate portfolio through
internal discovery and in-licensing of novel cancer therapeutics.
Sunesis is advancing its product candidates through in-house
research and development efforts and strategic collaborations with
leading pharmaceutical and biopharmaceutical companies. For further
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/. Forward-Looking Statements This press
release may contain forward-looking statements that involve
substantial risks and uncertainties. Sunesis may not actually
achieve the plans, intentions or expectations contained in such
forward-looking statements. Actual results or events could differ
materially from the plans, intentions and expectations contained in
such forward-looking statements. Sunesis does not assume any
obligation to update any such forward-looking statements.
DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: investors, Eric
Bjerkholt, CFO of Sunesis Pharmaceuticals, Inc., +1-650-266-3717;
or media, Karen L. Bergman or Michelle Corral, both of BCC
Partners, +1-650-575-1509, or +1-415-794-8662, for Sunesis
Pharmaceuticals, Inc. Web site: http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles